Mediclinic International (ANHGY) Stock Price, News & Analysis

Company Overview

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

Key Stats

• Today's Range: $5.49 to $5.49
• 50-Day Range: $5.49 to $5.49
• 52-Week Range: $5.49 to $5.58
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: N/A
• P/E Ratio: 7.95
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ANHGY Stock Analysis - Frequently Asked Questions

How have ANHGY shares performed this year?

Mediclinic International's stock was trading at $5.49 on January 1st, 2025. Since then, ANHGY stock has increased by 0.0% and is now trading at $5.49.

How do I buy shares of Mediclinic International?

Shares of ANHGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTC
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: OTC:ANHGY
• CIK: N/A
• Web: www.mediclinic.com
• Phone: 27 21 809 6500
• Fax: N/A
• Employees: 33,683
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 7.95
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A